FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis
Europe - FRA:FRE - DE0005785604 - Common Stock
48.28 EUR
+0.15 (+0.31%)
We assign a fundamental rating of 4 out of 10 to FRE. FRE was compared to 31 industry peers in the Health Care Providers & Services industry. FRE has an average financial health and profitability rating. While showing a medium growth rate, FRE is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
FRE had positive earnings in the past year.
FRE had a positive operating cash flow in the past year.
Of the past 5 years FRE 4 years were profitable.
FRE had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 2.72%, FRE is in line with its industry, outperforming 58.06% of the companies in the same industry.
FRE has a Return On Equity (6.15%) which is in line with its industry peers.
FRE has a worse Return On Invested Capital (3.29%) than 67.74% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FRE is below the industry average of 6.26%.
The 3 year average ROIC (1.83%) for FRE is below the current ROIC(3.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.72% | ||
| ROE | 6.15% | ||
| ROIC | 3.29% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
1.3 Margins
FRE's Profit Margin of 5.06% is amongst the best of the industry. FRE outperforms 83.87% of its industry peers.
In the last couple of years the Profit Margin of FRE has declined.
With an excellent Operating Margin value of 9.96%, FRE belongs to the best of the industry, outperforming 80.65% of the companies in the same industry.
FRE's Operating Margin has declined in the last couple of years.
FRE has a Gross Margin (25.40%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of FRE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.96% | ||
| PM (TTM) | 5.06% | ||
| GM | 25.4% |
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
2. Health
2.1 Basic Checks
FRE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
FRE has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, FRE has more shares outstanding
Compared to 1 year ago, FRE has an improved debt to assets ratio.
2.2 Solvency
FRE has an Altman-Z score of 2.11. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
FRE has a Altman-Z score of 2.11. This is comparable to the rest of the industry: FRE outperforms 54.84% of its industry peers.
FRE has a debt to FCF ratio of 10.07. This is a negative value and a sign of low solvency as FRE would need 10.07 years to pay back of all of its debts.
FRE's Debt to FCF ratio of 10.07 is in line compared to the rest of the industry. FRE outperforms 48.39% of its industry peers.
FRE has a Debt/Equity ratio of 0.61. This is a neutral value indicating FRE is somewhat dependend on debt financing.
FRE's Debt to Equity ratio of 0.61 is amongst the best of the industry. FRE outperforms 80.65% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 2.11 |
ROIC/WACC0.63
WACC5.27%
2.3 Liquidity
FRE has a Current Ratio of 1.31. This is a normal value and indicates that FRE is financially healthy and should not expect problems in meeting its short term obligations.
FRE has a Current ratio of 1.31. This is in the better half of the industry: FRE outperforms 67.74% of its industry peers.
A Quick Ratio of 1.00 indicates that FRE may have some problems paying its short term obligations.
FRE has a better Quick ratio (1.00) than 61.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1090.91%, which is quite impressive.
The Earnings Per Share has been decreasing by -2.29% on average over the past years.
FRE shows a small growth in Revenue. In the last year, the Revenue has grown by 0.89%.
Measured over the past years, FRE shows a decrease in Revenue. The Revenue has been decreasing by -9.22% on average per year.
EPS 1Y (TTM)1090.91%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%6.17%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
3.2 Future
FRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.89% yearly.
The Revenue is expected to grow by 4.79% on average over the next years.
EPS Next Y13.47%
EPS Next 2Y11.01%
EPS Next 3Y10.1%
EPS Next 5Y9.89%
Revenue Next Year4.78%
Revenue Next 2Y4.9%
Revenue Next 3Y4.87%
Revenue Next 5Y4.79%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 14.76, FRE is valued correctly.
FRE's Price/Earnings ratio is a bit cheaper when compared to the industry. FRE is cheaper than 61.29% of the companies in the same industry.
FRE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.77, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 13.02, FRE is valued correctly.
FRE's Price/Forward Earnings ratio is in line with the industry average.
FRE is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.23, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.76 | ||
| Fwd PE | 13.02 |
4.2 Price Multiples
The rest of the industry has a similar Enterprise Value to EBITDA ratio as FRE.
FRE's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. FRE is more expensive than 64.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.33 | ||
| EV/EBITDA | 10.53 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.1
PEG (5Y)N/A
EPS Next 2Y11.01%
EPS Next 3Y10.1%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 2.12%, FRE has a reasonable but not impressive dividend return.
FRE's Dividend Yield is a higher than the industry average which is at 2.52.
FRE's Dividend Yield is comparable with the S&P500 average which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.12% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
FRE pays out 58.31% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP58.31%
EPS Next 2Y11.01%
EPS Next 3Y10.1%
FRA:FRE (10/22/2025, 5:36:15 PM)
48.28
+0.15 (+0.31%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners44.2%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.19B
Revenue(TTM)22.23B
Net Income(TTM)1.13B
Analysts85.22
Price Target51.22 (6.09%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.12% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP58.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.26%
Min EPS beat(2)8.91%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.92%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.85%
EPS beat(12)6
Avg EPS beat(12)-41.15%
EPS beat(16)8
Avg EPS beat(16)-31.82%
Revenue beat(2)2
Avg Revenue beat(2)2.07%
Min Revenue beat(2)1.31%
Max Revenue beat(2)2.84%
Revenue beat(4)4
Avg Revenue beat(4)1.74%
Min Revenue beat(4)0.41%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.11%
Revenue beat(16)6
Avg Revenue beat(16)0%
PT rev (1m)0.63%
PT rev (3m)3.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.31%
EPS NY rev (1m)3.06%
EPS NY rev (3m)3.07%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.22%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)-0.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.76 | ||
| Fwd PE | 13.02 | ||
| P/S | 1.22 | ||
| P/FCF | 21.33 | ||
| P/OCF | 12.09 | ||
| P/B | 1.49 | ||
| P/tB | 18.7 | ||
| EV/EBITDA | 10.53 |
EPS(TTM)3.27
EY6.77%
EPS(NY)3.71
Fwd EY7.68%
FCF(TTM)2.26
FCFY4.69%
OCF(TTM)3.99
OCFY8.27%
SpS39.46
BVpS32.46
TBVpS2.58
PEG (NY)1.1
PEG (5Y)N/A
Graham Number48.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.72% | ||
| ROE | 6.15% | ||
| ROCE | 6.7% | ||
| ROIC | 3.29% | ||
| ROICexc | 3.6% | ||
| ROICexgc | 7.96% | ||
| OM | 9.96% | ||
| PM (TTM) | 5.06% | ||
| GM | 25.4% | ||
| FCFM | 5.74% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score8
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 3.32 | ||
| Cap/Depr | 86.89% | ||
| Cap/Sales | 4.38% | ||
| Interest Coverage | 6.1 | ||
| Cash Conversion | 67.46% | ||
| Profit Quality | 113.33% | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.11 |
F-Score8
WACC5.27%
ROIC/WACC0.63
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1090.91%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%6.17%
EPS Next Y13.47%
EPS Next 2Y11.01%
EPS Next 3Y10.1%
EPS Next 5Y9.89%
Revenue 1Y (TTM)0.89%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%2.22%
Revenue Next Year4.78%
Revenue Next 2Y4.9%
Revenue Next 3Y4.87%
Revenue Next 5Y4.79%
EBIT growth 1Y69.58%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year66.43%
EBIT Next 3Y24.05%
EBIT Next 5Y15.46%
FCF growth 1Y-50.31%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-49.36%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%